| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 6.53e-06 | 38 | 64 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.82e-05 | 118 | 64 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 6.87e-05 | 25 | 64 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.39e-05 | 230 | 64 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.41e-04 | 614 | 64 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | G-quadruplex RNA binding | 4.48e-04 | 10 | 64 | 2 | GO:0002151 | |
| GeneOntologyBiologicalProcess | lung induction | 2.84e-05 | 3 | 64 | 2 | GO:0060492 | |
| GeneOntologyBiologicalProcess | foregut regionalization | 2.84e-05 | 3 | 64 | 2 | GO:0060423 | |
| GeneOntologyBiologicalProcess | lung field specification | 2.84e-05 | 3 | 64 | 2 | GO:0060424 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 3.61e-05 | 60 | 64 | 4 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of telomeric DNA binding | 5.66e-05 | 4 | 64 | 2 | GO:1904742 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 6.26e-05 | 69 | 64 | 4 | GO:1904356 | |
| GeneOntologyBiologicalProcess | primary lung bud formation | 9.42e-05 | 5 | 64 | 2 | GO:0060431 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 9.62e-05 | 77 | 64 | 4 | GO:0007004 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 1.07e-04 | 475 | 64 | 8 | GO:0140694 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.29e-04 | 83 | 64 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 1.33e-04 | 32 | 64 | 3 | GO:0070198 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 1.45e-04 | 33 | 64 | 3 | GO:1904357 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.48e-04 | 86 | 64 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.69e-04 | 89 | 64 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.74e-04 | 266 | 64 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.76e-04 | 90 | 64 | 4 | GO:0010833 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in lung morphogenesis | 1.97e-04 | 7 | 64 | 2 | GO:0061046 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 2.28e-04 | 531 | 64 | 8 | GO:0042692 | |
| GeneOntologyBiologicalProcess | chromosome organization | 2.54e-04 | 686 | 64 | 9 | GO:0051276 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue morphogenesis | 2.62e-04 | 8 | 64 | 2 | GO:0055009 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 2.80e-04 | 854 | 64 | 10 | GO:1903047 | |
| GeneOntologyBiologicalProcess | muscle structure development | 2.90e-04 | 858 | 64 | 10 | GO:0061061 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 3.00e-04 | 42 | 64 | 3 | GO:0032205 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 3.42e-04 | 564 | 64 | 8 | GO:0051052 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 4.07e-04 | 112 | 64 | 4 | GO:0032204 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | EP400 SUPT6H SMC1A BCL7C BCL7B XRN1 CDADC1 DKC1 PINX1 TNKS TOP1MT | 4.49e-04 | 1081 | 64 | 11 | GO:0006259 |
| GeneOntologyBiologicalProcess | iris morphogenesis | 5.12e-04 | 11 | 64 | 2 | GO:0061072 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 5.63e-04 | 122 | 64 | 4 | GO:0055013 | |
| GeneOntologyBiologicalProcess | organelle assembly | 6.90e-04 | 1138 | 64 | 11 | GO:0070925 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 7.57e-04 | 132 | 64 | 4 | GO:0055006 | |
| GeneOntologyCellularComponent | myosin filament | 1.09e-06 | 25 | 66 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.75e-06 | 28 | 66 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.63e-05 | 16 | 66 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 3.62e-05 | 59 | 66 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 4.46e-04 | 576 | 66 | 8 | GO:0015629 | |
| GeneOntologyCellularComponent | midbody | 6.82e-04 | 222 | 66 | 5 | GO:0030496 | |
| GeneOntologyCellularComponent | ATPase complex | 7.42e-04 | 129 | 66 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | GBAF complex | 8.72e-04 | 14 | 66 | 2 | GO:0140288 | |
| Domain | Myosin_N | 1.66e-07 | 15 | 64 | 4 | PF02736 | |
| Domain | Myosin_N | 1.66e-07 | 15 | 64 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 3.70e-07 | 18 | 64 | 4 | PF01576 | |
| Domain | Myosin_tail | 3.70e-07 | 18 | 64 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.67e-07 | 19 | 64 | 4 | IPR027401 | |
| Domain | - | 4.67e-07 | 19 | 64 | 4 | 4.10.270.10 | |
| Domain | IQ | 4.41e-06 | 71 | 64 | 5 | PF00612 | |
| Domain | IQ | 8.45e-06 | 81 | 64 | 5 | SM00015 | |
| Domain | Myosin_head_motor_dom | 8.48e-06 | 38 | 64 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.48e-06 | 38 | 64 | 4 | PS51456 | |
| Domain | Myosin_head | 8.48e-06 | 38 | 64 | 4 | PF00063 | |
| Domain | MYSc | 8.48e-06 | 38 | 64 | 4 | SM00242 | |
| Domain | Wnt2 | 1.16e-05 | 2 | 64 | 2 | IPR009140 | |
| Domain | IQ_motif_EF-hand-BS | 1.42e-05 | 90 | 64 | 5 | IPR000048 | |
| Domain | IQ | 1.66e-05 | 93 | 64 | 5 | PS50096 | |
| Domain | BCL_N | 3.46e-05 | 3 | 64 | 2 | PF04714 | |
| Domain | BCL7 | 3.46e-05 | 3 | 64 | 2 | IPR006804 | |
| Domain | Myosin_S1_N | 1.15e-04 | 5 | 64 | 2 | IPR008989 | |
| Domain | P-loop_NTPase | 5.77e-04 | 848 | 64 | 10 | IPR027417 | |
| Domain | Band_7 | 6.23e-04 | 11 | 64 | 2 | IPR001107 | |
| Domain | Band_7 | 6.23e-04 | 11 | 64 | 2 | PF01145 | |
| Domain | PHB | 6.23e-04 | 11 | 64 | 2 | SM00244 | |
| Domain | Wnt | 1.90e-03 | 19 | 64 | 2 | IPR005817 | |
| Domain | Wnt_CS | 1.90e-03 | 19 | 64 | 2 | IPR018161 | |
| Domain | wnt | 1.90e-03 | 19 | 64 | 2 | PF00110 | |
| Domain | WNT1 | 1.90e-03 | 19 | 64 | 2 | SM00097 | |
| Domain | WNT1 | 1.90e-03 | 19 | 64 | 2 | PS00246 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.39e-03 | 35 | 64 | 2 | IPR002464 | |
| Pathway | KEGG_TIGHT_JUNCTION | 9.14e-05 | 132 | 49 | 5 | M11355 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 9.98e-05 | 70 | 49 | 4 | M12294 | |
| Pubmed | NEFL MYH3 MYH6 PRDM8 MYH10 MYH11 ATP6V1G2 UBXN4 IFT81 XRN1 PKHD1 NFXL1 DKC1 RDX KIF5B CFAP210 TOP1MT RPL7A | 1.22e-10 | 1442 | 66 | 18 | 35575683 | |
| Pubmed | CUTA MYH10 MYH11 CCDC124 EP400 CDK12 SELENOH BCL7B DKC1 PINX1 RDX LAMC1 ABT1 KIF5B FLOT1 GADD45GIP1 LRRFIP1 | 4.91e-10 | 1371 | 66 | 17 | 36244648 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NEFL EP400 SUPT6H SMC1A C19orf47 DKC1 EXOC3 LAMC1 KIF5B FLOT1 GADD45GIP1 RPL7A NCDN STOML2 DHX30 | 6.46e-10 | 1024 | 66 | 15 | 24711643 |
| Pubmed | NEFL MYH6 MYH10 MYH11 ATP6V1G2 SARS1 XRN1 RDX KIF5B FLOT1 TRIP11 RPL7A NCDN STOML2 LRRFIP1 DHX30 | 7.60e-09 | 1431 | 66 | 16 | 37142655 | |
| Pubmed | GPRASP1 NEFL MYH10 CCDC124 APC2 PLCB1 RDX TNKS KIF5B TRIP11 NCDN STOML2 LRRFIP1 | 2.73e-08 | 963 | 66 | 13 | 28671696 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NEFL MYH10 MYH11 UBXN4 SUPT6H SMC1A RDX LAMC1 KIF5B FLOT1 RPL7A LRRFIP1 | 5.94e-08 | 847 | 66 | 12 | 35235311 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CDK12 SMC1A C19orf47 XRN1 DKC1 PINX1 BUD13 ABT1 RPL7A LRRFIP1 DHX30 | 1.80e-07 | 759 | 66 | 11 | 35915203 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 SMC1A DKC1 RDX ABT1 KIF5B TOP1MT FLOT1 RPL7A LRRFIP1 DHX30 | 2.02e-07 | 949 | 66 | 12 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 CCDC124 SARS1 SUPT6H SMC1A DKC1 RDX KIF5B RPL7A NCDN LRRFIP1 DHX30 SPINK5 RPAP2 | 3.40e-07 | 1415 | 66 | 14 | 28515276 |
| Pubmed | 4.17e-07 | 653 | 66 | 10 | 33742100 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NEFL MYH10 CCDC124 EP400 CDK12 SUPT6H SMC1A DKC1 BUD13 FLOT1 RPL7A DHX30 | 8.10e-07 | 1082 | 66 | 12 | 38697112 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH10 CCDC124 EP400 CDK12 XRN1 DKC1 RDX KIF5B TRIP11 RPL7A DHX30 | 1.38e-06 | 934 | 66 | 11 | 33916271 |
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 8424456 | ||
| Pubmed | MYH10 GBP6 CCDC124 SMC1A KIF5B RPL7A ALPK2 STOML2 LRRFIP1 DHX30 | 2.86e-06 | 809 | 66 | 10 | 32129710 | |
| Pubmed | 2.98e-06 | 469 | 66 | 8 | 37314180 | ||
| Pubmed | MYH10 SARS1 SMC1A XRN1 BUD13 RDX KIF5B FLOT1 RPL7A STOML2 DHX30 RPAP2 | 3.52e-06 | 1247 | 66 | 12 | 27684187 | |
| Pubmed | Differential regulation of WNT2 and WNT2B expression in human cancer. | 3.55e-06 | 2 | 66 | 2 | 11712082 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 16316347 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 3.55e-06 | 2 | 66 | 2 | 10906735 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 7916668 | ||
| Pubmed | 7.33e-06 | 245 | 66 | 6 | 21182205 | ||
| Pubmed | 8.14e-06 | 538 | 66 | 8 | 28524877 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 8620598 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16973711 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 1.06e-05 | 3 | 66 | 2 | 1939265 | |
| Pubmed | The BCL7 gene family: deletion of BCL7B in Williams syndrome. | 1.06e-05 | 3 | 66 | 2 | 9931421 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 1.06e-05 | 3 | 66 | 2 | 1694848 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 8605326 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.16e-05 | 565 | 66 | 8 | 25468996 | |
| Pubmed | 1.46e-05 | 25 | 66 | 3 | 15136151 | ||
| Pubmed | 1.72e-05 | 786 | 66 | 9 | 29128334 | ||
| Pubmed | 1.81e-05 | 601 | 66 | 8 | 33658012 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 1.87e-05 | 604 | 66 | 8 | 37616343 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.02e-05 | 440 | 66 | 7 | 34244565 | |
| Pubmed | UBXN4 SARS1 SUPT6H IFT81 NFXL1 EXOC3 LAMC1 FLOT1 RPL7A NCDN STOML2 DHX30 | 2.06e-05 | 1487 | 66 | 12 | 33957083 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 27068743 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 20660156 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 36463205 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 8482409 | ||
| Pubmed | 2.31e-05 | 300 | 66 | 6 | 28561026 | ||
| Pubmed | 2.64e-05 | 634 | 66 | 8 | 34591612 | ||
| Pubmed | GPRASP1 NEFL SMC1A IFT81 APC2 RDX TNKS FLOT1 TRIP11 LRRFIP1 DHX30 | 2.79e-05 | 1285 | 66 | 11 | 35914814 | |
| Pubmed | 2.91e-05 | 92 | 66 | 4 | 37343697 | ||
| Pubmed | 3.23e-05 | 191 | 66 | 5 | 33762435 | ||
| Pubmed | 3.26e-05 | 653 | 66 | 8 | 22586326 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.26e-05 | 853 | 66 | 9 | 28718761 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 3.30e-05 | 475 | 66 | 7 | 31040226 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 3.53e-05 | 5 | 66 | 2 | 2277065 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 3.53e-05 | 5 | 66 | 2 | 11121372 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.22e-05 | 202 | 66 | 5 | 33005030 | |
| Pubmed | 4.22e-05 | 202 | 66 | 5 | 24639526 | ||
| Pubmed | 4.39e-05 | 497 | 66 | 7 | 23414517 | ||
| Pubmed | 4.42e-05 | 204 | 66 | 5 | 25659154 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 EP400 SMC1A XRN1 NFXL1 DKC1 EXOC3 KIF5B RPL7A STOML2 DHX30 | 4.46e-05 | 1353 | 66 | 11 | 29467282 |
| Pubmed | 4.56e-05 | 339 | 66 | 6 | 37232246 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 5.25e-05 | 38 | 66 | 3 | 21041481 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 28381556 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 23250740 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 10906778 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 23644491 | ||
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 12226091 | ||
| Pubmed | The SWI/SNF subunit Bcl7a contributes to motor coordination and Purkinje cell function. | 5.29e-05 | 6 | 66 | 2 | 29213114 | |
| Pubmed | GPRASP1 MYH10 UBXN4 XRN1 PLCB1 KIF5B FLOT1 RPL7A STOML2 LRRFIP1 | 5.44e-05 | 1139 | 66 | 10 | 36417873 | |
| Pubmed | 5.66e-05 | 916 | 66 | 9 | 32203420 | ||
| Pubmed | MYH11 CCDC124 CDK12 SMC1A SCN3A BUD13 KIF5B GADD45GIP1 RPL7A DHX30 | 6.03e-05 | 1153 | 66 | 10 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SH2D4A SMC1A BCL7B DKC1 EXOC3 BUD13 FLOT1 NCDN FAM110B DHX30 | 6.12e-05 | 1155 | 66 | 10 | 20360068 |
| Pubmed | 6.13e-05 | 40 | 66 | 3 | 24680892 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 SARS1 SUPT6H SMC1A DKC1 RDX KIF5B FLOT1 RPL7A STOML2 DHX30 | 7.11e-05 | 1425 | 66 | 11 | 30948266 |
| Pubmed | 7.19e-05 | 731 | 66 | 8 | 29298432 | ||
| Pubmed | Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects. | 7.40e-05 | 7 | 66 | 2 | 26950371 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 16819597 | ||
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 21126233 | ||
| Pubmed | An essential role for connexin43 gap junctions in mouse coronary artery development. | 7.40e-05 | 7 | 66 | 2 | 11934868 | |
| Pubmed | Characterization of LGALS3 (galectin-3) as a player in DNA damage response. | 9.35e-05 | 46 | 66 | 3 | 24755837 | |
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 3864153 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 33424621 | ||
| Pubmed | 1.01e-04 | 568 | 66 | 7 | 37774976 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.07e-04 | 774 | 66 | 8 | 15302935 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NEFL MYH10 UBXN4 SARS1 SELENOH DKC1 FLOT1 TRIP11 GADD45GIP1 STOML2 DHX30 | 1.09e-04 | 1496 | 66 | 11 | 32877691 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.15e-04 | 1005 | 66 | 9 | 19615732 | |
| Pubmed | 1.16e-04 | 131 | 66 | 4 | 28634551 | ||
| Pubmed | Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. | 1.27e-04 | 9 | 66 | 2 | 11092808 | |
| Pubmed | Multiple genetic variants in telomere pathway genes and breast cancer risk. | 1.27e-04 | 9 | 66 | 2 | 20056641 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.49e-04 | 605 | 66 | 7 | 28977666 | |
| Pubmed | GPRASP1 MYH3 PRDM8 ATP6V1G2 UBXN4 CCDC124 SARS1 SMC1A IFT81 KIF5B | 1.55e-04 | 1293 | 66 | 10 | 15342556 | |
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 1.58e-04 | 10 | 66 | 2 | 16258938 | |
| Pubmed | 1.68e-04 | 430 | 66 | 6 | 32581705 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH10 EP400 SMC1A C19orf47 DKC1 RDX TOP1MT RPL7A STOML2 DHX30 | 1.81e-04 | 1318 | 66 | 10 | 30463901 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NEFL SH2D4A SMC1A IFT81 CDADC1 EXOC3 TRIP11 STOML2 FAM110B DHX30 | 1.84e-04 | 1321 | 66 | 10 | 27173435 |
| Pubmed | 1.92e-04 | 441 | 66 | 6 | 31239290 | ||
| Pubmed | 1.93e-04 | 11 | 66 | 2 | 31045206 | ||
| Pubmed | Ozz-E3 ubiquitin ligase targets sarcomeric embryonic myosin heavy chain during muscle development. | 1.93e-04 | 11 | 66 | 2 | 20352047 | |
| Pubmed | Loss-of-function variants in myocardin cause congenital megabladder in humans and mice. | 1.93e-04 | 11 | 66 | 2 | 31513549 | |
| Pubmed | 1.97e-04 | 59 | 66 | 3 | 31551363 | ||
| Pubmed | 2.06e-04 | 638 | 66 | 7 | 33239621 | ||
| Pubmed | 2.07e-04 | 60 | 66 | 3 | 20682791 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.14e-04 | 857 | 66 | 8 | 25609649 | |
| Pubmed | 2.21e-04 | 645 | 66 | 7 | 25281560 | ||
| Pubmed | Molecular mechanisms underlying inner ear patterning defects in kreisler mutants. | 2.31e-04 | 12 | 66 | 2 | 16325169 | |
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 15778975 | ||
| Interaction | KIF20A interactions | NEFL MYH10 MYH11 SUPT6H APC2 XRN1 DKC1 TNKS CFAP210 TOP1MT FLOT1 TRIP11 GADD45GIP1 STOML2 DHX30 | 1.15e-06 | 1052 | 66 | 15 | int:KIF20A |
| Interaction | CCDC8 interactions | NEFL EP400 SMC1A C19orf47 EXOC3 LAMC1 FLOT1 GADD45GIP1 RPL7A NCDN STOML2 DHX30 | 1.26e-06 | 656 | 66 | 12 | int:CCDC8 |
| Interaction | KCTD13 interactions | GPRASP1 NEFL MYH6 MYH10 MYH11 ATP6V1G2 SARS1 XRN1 RDX KIF5B FLOT1 TRIP11 RPL7A NCDN STOML2 LRRFIP1 DHX30 | 1.68e-06 | 1394 | 66 | 17 | int:KCTD13 |
| Interaction | ZNF2 interactions | 6.42e-06 | 80 | 66 | 5 | int:ZNF2 | |
| Interaction | H2AC17 interactions | 1.07e-05 | 232 | 66 | 7 | int:H2AC17 | |
| Interaction | FGF8 interactions | 2.77e-05 | 108 | 66 | 5 | int:FGF8 | |
| Interaction | PRKRA interactions | 4.72e-05 | 400 | 66 | 8 | int:PRKRA | |
| Interaction | HECTD1 interactions | MYH10 CDK12 SMC1A C19orf47 XRN1 DKC1 PINX1 BUD13 ABT1 RPL7A LRRFIP1 DHX30 | 7.36e-05 | 984 | 66 | 12 | int:HECTD1 |
| Interaction | ABCE1 interactions | 7.96e-05 | 431 | 66 | 8 | int:ABCE1 | |
| Interaction | PURG interactions | 8.96e-05 | 223 | 66 | 6 | int:PURG | |
| Interaction | ZC3H3 interactions | 9.65e-05 | 226 | 66 | 6 | int:ZC3H3 | |
| Interaction | MYCN interactions | MYH10 EP400 CDK12 SELENOH BCL7C BCL7B DKC1 PINX1 BUD13 ABT1 GADD45GIP1 RPL7A DHX30 RPAP2 | 1.18e-04 | 1373 | 66 | 14 | int:MYCN |
| Interaction | DGCR8 interactions | 1.40e-04 | 242 | 66 | 6 | int:DGCR8 | |
| Interaction | MAGEB2 interactions | 1.43e-04 | 349 | 66 | 7 | int:MAGEB2 | |
| Interaction | OBSL1 interactions | NEFL CUTA EP400 SUPT6H SMC1A DKC1 FLOT1 RPL7A ALPK2 STOML2 DHX30 | 1.53e-04 | 902 | 66 | 11 | int:OBSL1 |
| Interaction | GMIP interactions | 1.87e-04 | 34 | 66 | 3 | int:GMIP | |
| Interaction | POLR1G interactions | 1.90e-04 | 489 | 66 | 8 | int:POLR1G | |
| Interaction | FGFBP1 interactions | 1.94e-04 | 257 | 66 | 6 | int:FGFBP1 | |
| GeneFamily | Myosin heavy chains | 2.75e-08 | 15 | 40 | 4 | 1098 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.97e-04 | 19 | 40 | 2 | 360 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.07e-03 | 43 | 40 | 2 | 409 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 178 | 66 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-06 | 176 | 66 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 187 | 66 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-06 | 188 | 66 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-5|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 9.48e-06 | 191 | 66 | 5 | f2fe8fe316e449f452075aa37d5e31917221a335 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-6|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.02e-05 | 194 | 66 | 5 | 84a539ce22ae6f5846f26a45cfc8beb559e2f5ea | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-1|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.69e-05 | 126 | 66 | 4 | 716726d0e39a6ef71565ad197b1a2b878dd4c01a | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.73e-05 | 141 | 66 | 4 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.33e-05 | 52 | 66 | 3 | c134eb63bd1969af2af7f8de5989e19063533865 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sla_(Layer6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.33e-05 | 52 | 66 | 3 | 14971277db09343d668e4f5a82ca2b6a92326251 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.13e-04 | 168 | 66 | 4 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 168 | 66 | 4 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.13e-04 | 168 | 66 | 4 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 169 | 66 | 4 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.18e-04 | 170 | 66 | 4 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.18e-04 | 170 | 66 | 4 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.18e-04 | 170 | 66 | 4 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 177 | 66 | 4 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 178 | 66 | 4 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 180 | 66 | 4 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 66 | 4 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 66 | 4 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.74e-04 | 188 | 66 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 66 | 4 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.77e-04 | 189 | 66 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 66 | 4 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 190 | 66 | 4 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 191 | 66 | 4 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 191 | 66 | 4 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 191 | 66 | 4 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 191 | 66 | 4 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 191 | 66 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-04 | 192 | 66 | 4 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 193 | 66 | 4 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 193 | 66 | 4 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 193 | 66 | 4 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 193 | 66 | 4 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-04 | 193 | 66 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 1.96e-04 | 194 | 66 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 195 | 66 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 195 | 66 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.04e-04 | 196 | 66 | 4 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 196 | 66 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 196 | 66 | 4 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 77 | 66 | 3 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 197 | 66 | 4 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-5|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 2.08e-04 | 197 | 66 | 4 | b33999eadabecc94086e9a1fa26c5978729158e1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 197 | 66 | 4 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.12e-04 | 198 | 66 | 4 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-04 | 198 | 66 | 4 | 7f728ca6d5317890c6fcde3ce6c10c0970d49a05 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-04 | 198 | 66 | 4 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-04 | 198 | 66 | 4 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-04 | 199 | 66 | 4 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | (00)_Basal|World / shred by cell type by condition | 2.16e-04 | 199 | 66 | 4 | bc0201e77a1690e3e0a6ecd05cd105e1f5c0ba7b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-04 | 200 | 66 | 4 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-04 | 200 | 66 | 4 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.20e-04 | 200 | 66 | 4 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-04 | 200 | 66 | 4 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-04 | 200 | 66 | 4 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 200 | 66 | 4 | 49ad6e2337886367fbfa2a7c7366687b701ddf39 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-04 | 200 | 66 | 4 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 200 | 66 | 4 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.20e-04 | 200 | 66 | 4 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-04 | 200 | 66 | 4 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.93e-04 | 87 | 66 | 3 | aaca22b97a42a1c4a10c5da708d1462101814386 | |
| Drug | oxovanadium | 1.10e-06 | 120 | 64 | 6 | CID000024411 | |
| Drug | fast white | 5.86e-06 | 42 | 64 | 4 | CID000024008 | |
| Drug | formycin triphosphate | 1.28e-05 | 51 | 64 | 4 | CID000122274 | |
| Drug | 4-amino-2,6-dinitrotoluene | 1.95e-05 | 541 | 64 | 9 | ctd:C035207 | |
| Drug | purealin | 2.15e-05 | 58 | 64 | 4 | CID006419303 | |
| Drug | Fenton's reagent | 2.72e-05 | 21 | 64 | 3 | CID000160257 | |
| Drug | AC1L1DSW | 4.53e-05 | 70 | 64 | 4 | CID000002493 | |
| Drug | AC1L212F | 4.65e-05 | 4 | 64 | 2 | CID000013118 | |
| Drug | picrolonic acid | 4.65e-05 | 4 | 64 | 2 | CID000068369 | |
| Drug | BAPPs | 4.65e-05 | 4 | 64 | 2 | CID000134312 | |
| Drug | AC1L3UXH | 4.65e-05 | 4 | 64 | 2 | CID000065446 | |
| Drug | clenbuterol | 4.99e-05 | 142 | 64 | 5 | CID000002783 | |
| Disease | oleoyl-oleoyl-glycerol (18:1/18:1) [1] measurement | 6.07e-05 | 6 | 60 | 2 | EFO_0800497 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 6.12e-05 | 335 | 60 | 6 | EFO_0009931 | |
| Disease | cryptic phenotype measurement | 1.22e-04 | 47 | 60 | 3 | EFO_0021487 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.81e-04 | 10 | 60 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | smoking status measurement, forced expiratory volume | 2.21e-04 | 11 | 60 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.21e-04 | 11 | 60 | 2 | EFO_0800332 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.65e-04 | 12 | 60 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.65e-04 | 12 | 60 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | smoking status measurement, systolic blood pressure | 2.91e-04 | 156 | 60 | 4 | EFO_0006335, EFO_0006527 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.13e-04 | 13 | 60 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | smoking status measurement, diastolic blood pressure | 3.13e-04 | 159 | 60 | 4 | EFO_0006336, EFO_0006527 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.20e-04 | 15 | 60 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | vision disorder | 4.79e-04 | 16 | 60 | 2 | MONDO_0021084 | |
| Disease | coronary artery disease | 6.51e-04 | 1194 | 60 | 9 | EFO_0001645 | |
| Disease | Hypertriglyceridemia | 6.80e-04 | 19 | 60 | 2 | EFO_0004211 | |
| Disease | Calcium channel blocker use measurement | 9.38e-04 | 213 | 60 | 4 | EFO_0009930 | |
| Disease | handedness | 1.33e-03 | 106 | 60 | 3 | EFO_0009902 | |
| Disease | Prostatic Neoplasms | 1.56e-03 | 616 | 60 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.56e-03 | 616 | 60 | 6 | C0376358 | |
| Disease | Beta blocking agent use measurement | 1.64e-03 | 114 | 60 | 3 | EFO_0009929 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.81e-03 | 118 | 60 | 3 | EFO_0004329, EFO_0006336 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.94e-03 | 32 | 60 | 2 | DOID:332 (is_implicated_in) | |
| Disease | mean arterial pressure, unipolar depression | 1.94e-03 | 32 | 60 | 2 | EFO_0003761, EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRAAEKVADARKRKA | 16 | O95670 | |
| SLRAERIAKEKKALA | 2516 | Q96L91 | |
| KRFARLASKKAVEEL | 596 | Q9BRD0 | |
| GAELSRKKKERAAAA | 396 | Q9NYV4 | |
| AAKSAKATAALARRE | 176 | Q8N9M1 | |
| AKKSREREKSLEARA | 1681 | Q86TB3 | |
| AKEIARAVVEKRLAA | 81 | O60888 | |
| KLDAKAVERLKSNSR | 171 | Q9BWV3 | |
| VAKGRRKAEAENKAA | 291 | Q7L2E3 | |
| VRAETRSRAKDDIKK | 6 | Q9BQE9 | |
| DSEVQAKRAAKRVKI | 681 | Q06278 | |
| AERVKALESALKEAK | 871 | P33176 | |
| KERRAAEEAKSAIAK | 391 | P35241 | |
| DFAREKTKAAGLVRK | 36 | Q14582 | |
| KAVKAGDIDAKTRRR | 61 | Q9UBB6 | |
| KRKASEIKEAEAKAA | 831 | Q6ZNB6 | |
| ERARAKAKREAAKEI | 481 | Q9NQ38 | |
| AEAKRDAGIREAKAK | 181 | O75955 | |
| ERAEAQERVAKKKSA | 241 | Q96BK5 | |
| ERALSAVIATEKKKA | 181 | H3BV12 | |
| LTDREKAVAVDRAKK | 481 | Q6ZN66 | |
| KAVAVDRAKKEAAEK | 486 | Q6ZN66 | |
| RKSDAIFRAAKKDLL | 446 | Q6ZV29 | |
| DRFVRRKKKAAAAAG | 81 | Q9ULW3 | |
| AKAKAKLALAVARID | 841 | O95996 | |
| KEKLASLEREASVKR | 366 | Q8WYA0 | |
| VRAETRSRAKDDIKK | 6 | Q8WUZ0 | |
| VGFSRALAKEVARKK | 156 | Q8N4T8 | |
| RRDFAVVKALAKLKA | 371 | Q49MI3 | |
| KRLSAVERLEADKAK | 46 | Q8TC76 | |
| KRKKEARAAALAAAV | 196 | Q8TAE8 | |
| RADAAKALAEEAAKK | 1341 | P11047 | |
| ERALSAVIATEKKKA | 181 | I6L899 | |
| EARKKASVEARLKAA | 36 | O60645 | |
| QVVAEAAKTAKRKRE | 436 | O60832 | |
| RARRAEAKAAADAKK | 16 | Q96CT7 | |
| EDERKQRALAVASKK | 1606 | P35580 | |
| ARKTLKRADARDVAA | 81 | P59044 | |
| KLAEARLAAKRAARA | 21 | Q32MZ4 | |
| KTKARARAKQEARSE | 386 | Q5JY77 | |
| SKKKAAARDVTLENR | 491 | P49591 | |
| SVARIAKLEKAKAKE | 246 | P62424 | |
| AKRSAFVEVKKAARA | 381 | Q9NQV8 | |
| SSKEDKARQAEVKRL | 146 | Q9H173 | |
| SRDARNAEEKAKKAI | 1746 | P11055 | |
| ETLKAIADSRAKRKR | 3606 | P08F94 | |
| SLAAIEKRAAEEKAK | 21 | Q9NY46 | |
| RNAEEKAKKAITDAA | 1751 | P13533 | |
| TREAACLRAERKAKK | 66 | Q0VFZ6 | |
| EDERKQRALAAAAKK | 1606 | P35749 | |
| AAKASRKKLKRVREE | 481 | Q7KZ85 | |
| KDKVLVAARRNASAV | 121 | Q8NC42 | |
| FVDAKERKGKDARAL | 171 | P09544 | |
| DASKRKAELEAAVRK | 36 | Q8IXW5 | |
| AFAKRPRDDAKASEK | 6 | Q7RTT6 | |
| AAREADLAKVKKTLA | 496 | O95271 | |
| RKRKAEAAVVAVAEK | 6 | Q8IZQ5 | |
| RFRSAKEAEDKIKKA | 101 | Q8IZH2 | |
| VDKAAARKVLSREEK | 146 | Q969P6 | |
| TSDEFEAARKRAKKA | 1041 | Q14683 | |
| EAARKRAKKAKQAFE | 1046 | Q14683 | |
| LRKSKAADEKRRSLA | 236 | Q9H788 | |
| AVLAKAKAKAEAIRI | 246 | Q9UJZ1 | |
| RRRAALEKSAKKDSK | 961 | Q9NQ66 | |
| AAEDREAKLRKKVTV | 1601 | Q15643 | |
| VKTALKSARDAIRNK | 6 | Q6PGP7 | |
| ARFAKTKEEVEAAKA | 281 | Q92575 | |
| AFVDAKEKRLKDARA | 201 | Q93097 | |
| AKDEVSESRRLLKAK | 301 | P07196 |